BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23272176)

  • 1. Long-term engraftment of human natural T regulatory cells in NOD/SCID IL2rγc(null) mice by expression of human IL-2.
    Abraham S; Pahwa R; Ye C; Choi JG; Pahwa S; Jaggaiahgari S; Raut A; Chen S; Manjunath N; Shankar P
    PLoS One; 2012; 7(12):e51832. PubMed ID: 23272176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.
    Brehm MA; Kenney LL; Wiles MV; Low BE; Tisch RM; Burzenski L; Mueller C; Greiner DL; Shultz LD
    FASEB J; 2019 Mar; 33(3):3137-3151. PubMed ID: 30383447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.
    Ali N; Flutter B; Sanchez Rodriguez R; Sharif-Paghaleh E; Barber LD; Lombardi G; Nestle FO
    PLoS One; 2012; 7(8):e44219. PubMed ID: 22937164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHIP limits immunoregulatory capacity in the T-cell compartment.
    Collazo MM; Wood D; Paraiso KH; Lund E; Engelman RW; Le CT; Stauch D; Kotsch K; Kerr WG
    Blood; 2009 Mar; 113(13):2934-44. PubMed ID: 19136659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells.
    Hilger N; Glaser J; Müller C; Halbich C; Müller A; Schwertassek U; Lehmann J; Ruschpler P; Lange F; Boldt A; Stahl L; Sack U; Oelkrug C; Emmrich F; Fricke S
    Cytometry A; 2016 Sep; 89(9):803-15. PubMed ID: 27560708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
    Scalapino KJ; Daikh DI
    PLoS One; 2009 Jun; 4(6):e6031. PubMed ID: 19551149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
    Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
    Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
    Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
    Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo-expanded baboon CD39 +  regulatory T cells prevent rejection of porcine islet xenografts in NOD-SCID IL-2rγ
    Huang D; Wang Y; Hawthorne WJ; Hu M; Hawkes J; Burns H; Davies S; Gao F; Chew YV; Yi S; O'Connell PJ
    Xenotransplantation; 2017 Nov; 24(6):. PubMed ID: 28963731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.
    Janikashvili N; Trad M; Gautheron A; Samson M; Lamarthée B; Bonnefoy F; Lemaire-Ewing S; Ciudad M; Rekhviashvili K; Seaphanh F; Gaugler B; Perruche S; Bateman A; Martin L; Audia S; Saas P; Larmonier N; Bonnotte B
    J Allergy Clin Immunol; 2015 Jun; 135(6):1614-24.e4. PubMed ID: 25630940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.
    Hippen KL; Merkel SC; Schirm DK; Sieben CM; Sumstad D; Kadidlo DM; McKenna DH; Bromberg JS; Levine BL; Riley JL; June CH; Scheinberg P; Douek DC; Miller JS; Wagner JE; Blazar BR
    Sci Transl Med; 2011 May; 3(83):83ra41. PubMed ID: 21593401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
    Sgouroudis E; Albanese A; Piccirillo CA
    J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
    Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
    Giang S; Horwitz DA; Bickerton S; La Cava A
    Front Immunol; 2021; 12():628059. PubMed ID: 34122401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease.
    Sato K; Eizumi K; Fukaya T; Fujita S; Sato Y; Takagi H; Yamamoto M; Yamashita N; Hijikata A; Kitamura H; Ohara O; Yamasaki S; Saito T; Sato K
    Blood; 2009 May; 113(19):4780-9. PubMed ID: 19228924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].
    Gao L; Wang JM; Xie LN; Zhou H; Qiu HY
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):87-91. PubMed ID: 18681307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
    Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.